Biofrontera AG (B8FK) Turns H1 EBITDA Positive on 44% Revenue Growth

Biofrontera AG reported unaudited H1 2026 revenue of €9.0M, up 44% YoY, and EBITDA from continuing operations of €1.7M vs. -€1.3M. German sales rose 54% to €6.8M, aided by pre-price hike stocking; management expects this to unwind.Material DetailsContext by AI AnalystThis is an early confirmation o…